Prof. Kim to nominate a head of multinational clinical study.

Published: 2006-04-12 06:58:00

Updated: 2006-04-12 06:58:00

Prof. Kim Seon-woo of Sungkyunkwan Univ. Medical College Kangbuk Samsung hospital, was nominated as the chief of the multinational clinical studies (145 centers from 8 countries including Korea and the United States) of Galvus (vildagliptin), a new type of anti-diabetic drug developed by Novartis...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK